Blueshift Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Blueshift Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,286	Closed	-$326K	–	457
2023 Q2	$326K	Buy	+8,286	New	+$292K	0.12%	202
2023 Q1	–	Sell	-20,604	Closed	-$441K	–	485
2022 Q4	$441K	Buy	+20,604	New	+$440K	0.2%	141

Blueshift Asset Management's ISEE Position: Q3 2023 in Review

Blueshift Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 8,286 shares — an estimated $326K sold.

Blueshift Asset Management first reported a position in ISEE in Q4 2022 and held it in 2 quarters. The position peaked at $441K in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Blueshift Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Blueshift Asset Management sold 8,286 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $326K.
Blueshift Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Blueshift Asset Management's IVERIC bio, Inc. Common Stock position peaked at $441K in Q4 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Blueshift Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.